Promotes Infant Intestinal Health! Bifidobacterium longum subsp. infantis (B. infantis) is associated with improved growth‚ the development of intestinal membrane integrity‚ and is critical for developing immune function. B. infantis is the predominant intestinal organism found in breast-fed infants. B. infantis M-63 was isolated from a healthy infant and clinically proven to colonize the intestines of infants. B. infantis is the only bacterial species able to take up and metabolize all Human Milk Oligosaccharides (HMOs) which allows B. infantis to outcompete other bacterial species. Jarro-Dophilus Infant is formulated with Medium Chain Triglycerides (MCTs)‚ a component of breast milk. These statements have not been evaluated by the Food and Drug Administration (FDA). These products are not meant to diagnose‚ treat or cure any disease or medical condition. Please consult your doctor before starting any exercise or nutritional supplement program or before using these or any product during pregnancy or if you have a serious medical condition.